Literature DB >> 31390640

Lenvatinib Real-Life Experience.

Maurie Markman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31390640     DOI： 10.1159/000501641

Source DB:  PubMed          Journal:  Oncology        ISSN： 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  1 in total

1.  Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma - A Real-World Experience.

Authors:  He-Jiun Jiang; Yen-Hsiang Chang; Yen-Hao Chen; Che-Wei Wu; Pei-Wen Wang; Pi-Jung Hsiao
Journal:  Cancer Manag Res       Date:  2021-09-14       Impact factor: 3.989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.